Search the Roll Call archive by keyword, date, Congress, section, or tags.
For the vast majority (over 90%) of rare diseases lacking FDA-approved treatments, reducing barriers to R&D investment must remain the priority—especially when reducing these barriers would require remarkably
"If BA.2.86 takes off, it will be a real test of how good our T-cell response can rev up to meet the challenge," Scripps Research Translational Institute Director Eric Topol wrote on Substack late last
The Senate starts its week considering the nomination of Cory T. Wilson of Mississippi for a seat on the U.S.
Hassan, questioning FEMA Administrator Peter T.
Peter T. King of New York and Steve Stivers of Ohio voted just for the THUD bill. King had also supported the six-bill appropriations package the House passed last week.
Shelby, R-Ala., said last week.